Liao R - Search Results

1

An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury.

Zhang XJ, Cheng X, Yan ZZ, Fang J, Wang X, Wang W, Liu ZY, Shen LJ, Zhang P, Wang PX, Liao R, Ji YX, Wang JY, Tian S, Zhu XY, Zhang Y, Tian RF, Wang L, Ma XL, Huang Z, She ZG, Li H. Zhang XJ, et al. Among authors: liao r. Nat Med. 2018 Jan;24(1):73-83. doi: 10.1038/nm.4451. Epub 2017 Dec 11. Nat Med. 2018. PMID: 29227475

2

Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species.

Zhang XJ, Liu X, Hu M, Zhao GJ, Sun D, Cheng X, Xiang H, Huang YP, Tian RF, Shen LJ, Ma JP, Wang HP, Tian S, Gan S, Xu H, Liao R, Zou T, Ji YX, Zhang P, Cai J, Wang ZV, Meng G, Xu Q, Wang Y, Ma XL, Liu PP, Huang Z, Zhu L, She ZG, Zhang X, Bai L, Yang H, Lu Z, Li H. Zhang XJ, et al. Among authors: liao r. Cell Metab. 2021 Oct 5;33(10):2059-2075.e10. doi: 10.1016/j.cmet.2021.08.014. Epub 2021 Sep 17. Cell Metab. 2021. PMID: 34536344 Free article.

3

TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation.

Liu D, Zhang P, Zhou J, Liao R, Che Y, Gao MM, Sun J, Cai J, Cheng X, Huang Y, Chen G, Nie H, Ji YX, Zhang XJ, Huang Z, Xu H, She ZG, Li H. Liu D, et al. Among authors: liao r. Cell Metab. 2020 Apr 7;31(4):726-740.e8. doi: 10.1016/j.cmet.2020.03.007. Cell Metab. 2020. PMID: 32268115 Free article.

4

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis.

Jian C, Fu J, Cheng X, Shen LJ, Ji YX, Wang X, Pan S, Tian H, Tian S, Liao R, Song K, Wang HP, Zhang X, Wang Y, Huang Z, She ZG, Zhang XJ, Zhu L, Li H. Jian C, et al. Among authors: liao r. Cell Metab. 2020 May 5;31(5):892-908.e11. doi: 10.1016/j.cmet.2020.04.011. Cell Metab. 2020. PMID: 32375062 Free PMC article.

5

A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques.

Zhang XJ, Ji YX, Cheng X, Cheng Y, Yang H, Wang J, Zhao LP, Huang YP, Sun D, Xiang H, Shen LJ, Li PL, Ma JP, Tian RF, Yang J, Yao X, Xu H, Liao R, Xiao L, Zhang P, Zhang X, Zhao GN, Wang X, Hu ML, Tian S, Wan J, Cai J, Ma X, Xu Q, Wang Y, Touyz RM, Liu PP, Loomba R, She ZG, Li H. Zhang XJ, et al. Among authors: liao r. Sci Transl Med. 2021 Dec 15;13(624):eabg8116. doi: 10.1126/scitranslmed.abg8116. Epub 2021 Dec 15. Sci Transl Med. 2021. PMID: 34910548

6

Profound Perturbation in the Metabolome of a Canine Obesity and Metabolic Disorder Model.

Qu W, Chen Z, Hu X, Zou T, Huang Y, Zhang Y, Hu Y, Tian S, Wan J, Liao R, Bai L, Xue J, Ding Y, Hu M, Zhang XJ, Zhang X, Zhao J, Cheng X, She ZG, Li H. Qu W, et al. Among authors: liao r. Front Endocrinol (Lausanne). 2022 Apr 19;13:849060. doi: 10.3389/fendo.2022.849060. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35620391 Free PMC article.

7

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis.

Jian C, Fu J, Cheng X, Shen LJ, Ji YX, Wang X, Pan S, Tian H, Tian S, Liao R, Song K, Wang HP, Zhang X, Wang Y, Huang Z, She ZG, Zhang XJ, Zhu L, Li H. Jian C, et al. Among authors: liao r. Cell Metab. 2020 Jun 2;31(6):1206. doi: 10.1016/j.cmet.2020.05.006. Cell Metab. 2020. PMID: 32492395 Free PMC article. No abstract available.

8

Near-infrared light-triggered theranostics for tumor-specific enhanced multimodal imaging and photothermal therapy.

Wu B, Wan B, Lu ST, Deng K, Li XQ, Wu BL, Li YS, Liao RF, Huang SW, Xu HB. Wu B, et al. Int J Nanomedicine. 2017 Jun 16;12:4467-4478. doi: 10.2147/IJN.S137835. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28670120 Free PMC article.

9

Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy.

Lu ST, Xu D, Liao RF, Luo JZ, Liu YH, Qi ZH, Zhang CJ, Ye NL, Wu B, Xu HB. Lu ST, et al. Comput Struct Biotechnol J. 2019 Apr 13;17:619-627. doi: 10.1016/j.csbj.2019.04.005. eCollection 2019. Comput Struct Biotechnol J. 2019. PMID: 31193098 Free PMC article.

10

Evaluation of non-targeting, C- or N-pH (low) insertion peptide modified superparamagnetic iron oxide nanoclusters for selective MRI of liver tumors and their potential toxicity in cirrhosis.

Mahmood AA, Zhang J, Liao R, Pan X, Xu D, Xu H, Zhou Q. Mahmood AA, et al. Among authors: liao r. RSC Adv. 2019 May 7;9(25):14051-14059. doi: 10.1039/c9ra02430a. eCollection 2019 May 7. RSC Adv. 2019. PMID: 35519327 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,465 results

Search Page